Changes in Metabolic Status in Patients With Total Thyroidectomy (Thyroid cancer)
This study objective is to evaluate the change in mitochondrial uncoupling protein 2 (UCP2) mRNA expression as function of thyroid activity (TSH, T3 and Free T4).
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
- Changes in UCP2 mRNA concentrations. [ Time Frame: Base line (before opporation), 2 weeks after opporation and for after opporation. ] [ Designated as safety issue: No ]The difference between the result at two weeks and four months compare to base line.
- Weight [ Time Frame: Approximately 4 months ] [ Designated as safety issue: No ]
- Resting energy expenditure [ Time Frame: Approximatly 4 months ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Whole blood for UCP2 mRNA
|Study Start Date:||January 2013|
|Estimated Study Completion Date:||July 2014|
|Estimated Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
Blood will be drown before thyroidectomy, 2 weeks after the operation and 3-4 month after the operation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01781767
|Contact: Nachum Vaisman, M.D.||firstname.lastname@example.org|
|Tel Aviv Sourasky Medical Center||Recruiting|
|Tel Aviv, Israel, 64239|
|Contact: Nachum Vaisman, M.D. 972-3-6974807 email@example.com|